» Articles » PMID: 39346899

Combination of Aloe Emodin, Emodin, and Rhein from Aloe with EDTA Sensitizes the Resistant to Polymyxins

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The continuous emergence and spread of polymyxin-resistant pose a significant global health challenge, necessitating the development of novel therapeutic strategies. Aloe, with its long-standing history of medicinal use, has recently been the subject of substantial research for its efficacy against pathogenic infections.

Methods: This study investigates the potential application of anthraquinone components in aloe against polymyxin-resistant by liquid chromatography-mass spectrometry, in vitro activity assessment, and construction of animal infection models.

Results: The findings demonstrate that aloe emodin, emodin, rhein, and their mixtures in equal mass ratios (EAR) exhibit strain-specific antibacterial activities against polymyxin-resistant . Co-administration of EAR with EDTA synergistically and universally enhanced the antibacterial activity and bactericidal efficacy of polymyxins against polymyxin-resistant , while also reducing the frequency of polymyxin-resistant mutations in polymyxinssensitive . Following toxicity assessment on human hepatic and renal cell lines, the combination therapy was applied to skin wounds in mice infected with polymyxin-resistant . Compared to monotherapy, the combination therapy significantly accelerated wound healing and reduced bacterial burden.

Conclusions: The combination of EAR and EDTA with polymyxins offers a novel therapeutic approach for managing skin infections caused by polymyxinresistant .

References
1.
Yang Q, Pogue J, Li Z, Nation R, Kaye K, Li J . Agents of Last Resort: An Update on Polymyxin Resistance. Infect Dis Clin North Am. 2020; 34(4):723-750. DOI: 10.1016/j.idc.2020.08.003. View

2.
. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022; 400(10369):2221-2248. PMC: 9763654. DOI: 10.1016/S0140-6736(22)02185-7. View

3.
Zhao J, Zhu Y, Lin Y, Yu H, Wickremasinghe H, Han J . Polymyxin dose tunes the evolutionary dynamics of resistance in multidrug-resistant Acinetobacter baumannii. Clin Microbiol Infect. 2022; 28(7):1026.e1-1026.e5. DOI: 10.1016/j.cmi.2022.02.043. View

4.
Arip M, Selvaraja M, R M, Tan L, Leong M, Tan P . Review on Plant-Based Management in Combating Antimicrobial Resistance - Mechanistic Perspective. Front Pharmacol. 2022; 13:879495. PMC: 9557208. DOI: 10.3389/fphar.2022.879495. View

5.
Nair A, Jacob S . A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016; 7(2):27-31. PMC: 4804402. DOI: 10.4103/0976-0105.177703. View